Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion

Mol Cancer Res. 2006 Nov;4(11):831-41. doi: 10.1158/1541-7786.MCR-06-0153.

Abstract

Our previous reports show that matrilysin [matrix metalloproteinase (MMP)-7] is overexpressed in epithelial ovarian cancer (EOC) and recombinant MMP-7 promotes EOC invasion in vitro. In the present study, we further evaluated the correlation of MMP-7 expression to EOC invasiveness and examined its role in lysophosphatidic acid (LPA)-induced invasion. By sense and antisense gene transfection in vitro, we show that overexpression of MMP-7 in all MMP-7 stably transfected DOV13 clones significantly enhanced their invasiveness, although MMP-7 antisense transfection caused a 91% decrease of MMP-7 expression (P < 0.01) and 87% decrease of invasion (P < 0.05) in geneticin (G418)-selected DOV13 clone P47-M7As-3 compared with vector-transfected control. As assessed by MMP-7 ELISA, LPA treatment at 10 to 80 micromol/L significantly stimulated the secretion of total MMP-7 in DOV13 conditioned medium (P < 0.01). In addition, LPA apparently induced the activation of MMP-7 in DOV13 cells as detected by gelatin zymography. In the antisense MMP-7-transfected DOV13 clone (P47-M7As-3), LPA-increased invasion was significantly decreased compared with vector control. Moreover, knocking down of MMP-7 by small interfering RNA also suppressed LPA-induced invasion in two EOC cell lines (DOV13 and R182). Altogether, our results show that MMP-7 expression is correlated with EOC invasiveness and LPA-induced MMP-7 secretion/activation may represent a new mechanism that facilitates ovarian cancer invasion besides the well-known induction of MT1-MMP-mediated proMMP-2 activation by LPA.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma / enzymology*
  • Carcinoma / genetics
  • Carcinoma / pathology*
  • Female
  • Humans
  • Lysophospholipids / toxicity
  • Matrix Metalloproteinase 7 / drug effects
  • Matrix Metalloproteinase 7 / genetics
  • Matrix Metalloproteinase Inhibitors*
  • Neoplasm Invasiveness
  • Ovarian Neoplasms / enzymology*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Receptors, Lysophosphatidic Acid / agonists
  • Tumor Cells, Cultured

Substances

  • Lysophospholipids
  • Matrix Metalloproteinase Inhibitors
  • RNA, Small Interfering
  • Receptors, Lysophosphatidic Acid
  • Matrix Metalloproteinase 7
  • lysophosphatidic acid